Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations
โ Scribed by Philip J. Kuehl; Tim Brenner; Parijat K. Jain; Kelly Karlage; Kia Sepassi; Gang Yang; Michael Mayersohn; Samuel H. Yalkowsky; Paul B. Myrdal
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 259 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background Plasmid DNA (pDNA) vaccines have generated significant interest for the prevention or treatment of infectious diseases. Broader applications may benefit from the identification of safe and potent vaccine adjuvants. This report describes the development of a novel polymerโ
reversal tests are presented elsewhere. The resistant C. reinhardtii cells could present an opportunity to select the resistance gene by transformation experiments. If the resistance is due to target site alteration, which seems to be the case, this could lead to ยฎnding the target gene.
The bioavailability and pharmacokinetics of salicylic acid (SA) were studied after single and multiple doses of a new slow-release formulation, based on porous membrane diffusion of sodium salicylate (NaSA). A solution of NaSA and an enteric-coated tablet of NaSA were used for comparison. Dissolutio